Cabtreo™ (clindamycin phosphate/adapalene/benzoyl peroxide) – New drug approval
October 20, 2023 - Bausch Health announced the FDA approval of Cabtreo (clindamycin phosphate/adapalene/benzoyl peroxide), for the topical treatment of acne vulgaris in adult and pediatric patients 12 years of age and older.
Top